Incannex Ptb Ratio from 2010 to 2025

IXHL Stock  USD 1.78  0.11  5.82%   
Incannex Healthcare PTB Ratio yearly trend continues to be quite stable with very little volatility. PTB Ratio may rise above 5.13 this year. PTB Ratio is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on Incannex Healthcare's equity relative to its net asset value. View All Fundamentals
 
PTB Ratio  
First Reported
2010-12-31
Previous Quarter
4.89
Current Value
5.13
Quarterly Volatility
1.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incannex Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incannex Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 112.5 K, Interest Expense of 2.6 K or Selling General Administrative of 20.3 M, as well as many indicators such as Price To Sales Ratio of 4.3 K, Dividend Yield of 0.0 or PTB Ratio of 5.13. Incannex financial statements analysis is a perfect complement when working with Incannex Healthcare Valuation or Volatility modules.
  
Check out the analysis of Incannex Healthcare Correlation against competitors.

Latest Incannex Healthcare's Ptb Ratio Growth Pattern

Below is the plot of the Ptb Ratio of Incannex Healthcare Ltd over the last few years. It is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value. Incannex Healthcare's PTB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incannex Healthcare's overall financial position and show how it may be relating to other accounts over time.
Ptb Ratio10 Years Trend
Very volatile
   Ptb Ratio   
       Timeline  

Incannex Ptb Ratio Regression Statistics

Arithmetic Mean(648.44)
Geometric Mean78.59
Coefficient Of Variation(281.63)
Mean Deviation1,298
Median5.13
Standard Deviation1,826
Sample Variance3.3M
Range6.8K
R-Value0.05
Mean Square Error3.6M
R-Squared0
Significance0.86
Slope18.78
Total Sum of Squares50M

Incannex Ptb Ratio History

2025 5.13
2024 4.89
2023 4.25
2022 1.36
2021 46.42
2020 565.28
2019 1165.18

About Incannex Healthcare Financial Statements

Incannex Healthcare investors utilize fundamental indicators, such as Ptb Ratio, to predict how Incannex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
PTB Ratio 4.89  5.13 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:
Check out the analysis of Incannex Healthcare Correlation against competitors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.36)
Revenue Per Share
0.001
Quarterly Revenue Growth
0.296
Return On Assets
(0.57)
Return On Equity
(1.15)
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.